These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4939854)
1. Problems of a drug trial (Pemoline) on geriatric patients. Droller H; Bevans HG; Jayaram VK Gerontol Clin (Basel); 1971; 13(5):269-76. PubMed ID: 4939854 [No Abstract] [Full Text] [Related]
2. Effect of magnesium pemoline and methylphenidate on memory improvement and mood in normal aging subjects. Gilbert JG; Donnelly KJ; Zimmer LE; Kubis JF Int J Aging Hum Dev; 1973; 4(1):35-51. PubMed ID: 4591659 [No Abstract] [Full Text] [Related]
3. The clinical and psychological effects of pemoline in depressed patients--a controlled study. Elizur A; Wintner I; Davidson S Int Pharmacopsychiatry; 1979; 14(3):127-34. PubMed ID: 391753 [TBL] [Abstract][Full Text] [Related]
4. Influences of cylert upon memory changes with ECT. Small IF; Sharpley P; Small JG Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991 [No Abstract] [Full Text] [Related]
5. Clinical trial of pemoline in general practice. Kagan G Br J Clin Pract; 1974 Nov; 28(11):375-8. PubMed ID: 4618123 [No Abstract] [Full Text] [Related]
6. Clinical trial with amantadine and pemoline in elderly patients. Montanari C; Vallecorsi GF; Bavazzano A; D'Ayalavalva G; Sanesi P Age Ageing; 1976 Feb; 5(1):6-11. PubMed ID: 769506 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of pemoline and magnesium hydroxide as a mild stimulant in geriatric patients. Goldstein BJ; Braunstein J Curr Ther Res Clin Exp; 1968 Sep; 10(9):457-60. PubMed ID: 4386689 [No Abstract] [Full Text] [Related]
8. Hepatotoxicity due to pemoline. Report of two cases. Tolman KG; Freston JW; Berenson MM; Sannella JJ Digestion; 1973; 9(6):532-9. PubMed ID: 4787851 [TBL] [Abstract][Full Text] [Related]
9. Performance tests of amnesic patients with cylert. Talland GA; Hagen DQ; James M J Nerv Ment Dis; 1967 May; 144(5):421-9. PubMed ID: 4382435 [No Abstract] [Full Text] [Related]
12. Pemoline (Cylert) for minimal brain dysfunction. Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790 [No Abstract] [Full Text] [Related]
13. [Determination of the effect of the short-term administration of Pondex, methylphenidate, and placebo by various pshychological tests]. Sindelárová M; Bojanovský J Act Nerv Super (Praha); 1967 Nov; 9(4):374. PubMed ID: 4388630 [No Abstract] [Full Text] [Related]
14. Tests of learning and memory with Cylert. Talland GA; McGuire MT Psychopharmacologia; 1967; 10(5):445-51. PubMed ID: 4385231 [No Abstract] [Full Text] [Related]
15. [Physiological changes in the performance of older test persons during continuous tracking tasks following administration of a central nervous system stimulants]. Strasser H; Müller-Limmroth W Arzneimittelforschung; 1973 Mar; 23(3):406-15. PubMed ID: 4575176 [No Abstract] [Full Text] [Related]
17. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. Leckman J; Ananth JV; Ban TA; Lehmann HE J Clin Pharmacol New Drugs; 1971; 11(4):301-3. PubMed ID: 4932747 [No Abstract] [Full Text] [Related]
18. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction. Conners CK; Taylor E; Meo G; Kurtz MA; Fournier M Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756 [No Abstract] [Full Text] [Related]
19. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Conners CK Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496 [No Abstract] [Full Text] [Related]
20. Comparison of PMH (1) and pemoline activity after electroconvulsive shock. Plotnikoff N Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):175-85. PubMed ID: 5465078 [No Abstract] [Full Text] [Related] [Next] [New Search]